Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Effect of prolonged antibiotic treatment on cognition in patients with Lyme borreliosis.

Berende A, Ter Hofstede HJM, Vos FJ, Vogelaar ML, van Middendorp H, Evers AWM, Kessels RPC, Kullberg BJ.

Neurology. 2019 Mar 26;92(13):e1447-e1455. doi: 10.1212/WNL.0000000000007186. Epub 2019 Feb 22.

2.

Cost-effectiveness of longer-term versus shorter-term provision of antibiotics in patients with persistent symptoms attributed to Lyme disease.

Berende A, Nieuwenhuis L, Ter Hofstede HJM, Vos FJ, Vogelaar ML, Tromp M, van Middendorp H, Donders ART, Evers AWM, Kullberg BJ, Adang EMM.

PLoS One. 2018 Apr 2;13(4):e0195260. doi: 10.1371/journal.pone.0195260. eCollection 2018.

3.

Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease.

Berende A, ter Hofstede HJ, Vos FJ, van Middendorp H, Vogelaar ML, Tromp M, van den Hoogen FH, Donders AR, Evers AW, Kullberg BJ.

N Engl J Med. 2016 Mar 31;374(13):1209-20. doi: 10.1056/NEJMoa1505425.

4.

Persistent Lyme Empiric Antibiotic Study Europe (PLEASE)--design of a randomized controlled trial of prolonged antibiotic treatment in patients with persistent symptoms attributed to Lyme borreliosis.

Berende A, ter Hofstede HJ, Donders AR, van Middendorp H, Kessels RP, Adang EM, Vos FJ, Evers AW, Kullberg BJ.

BMC Infect Dis. 2014 Oct 16;14:543. doi: 10.1186/s12879-014-0543-y.

5.

Recognition of Borrelia burgdorferi by NOD2 is central for the induction of an inflammatory reaction.

Oosting M, Berende A, Sturm P, Ter Hofstede HJ, de Jong DJ, Kanneganti TD, van der Meer JW, Kullberg BJ, Netea MG, Joosten LA.

J Infect Dis. 2010 Jun 15;201(12):1849-58. doi: 10.1086/652871.

PMID:
20441518
6.

Stavudine plasma concentrations and lipoatrophy.

ter Hofstede HJ, Koopmans PP, Burger DM.

J Antimicrob Chemother. 2008 Apr;61(4):933-8. doi: 10.1093/jac/dkn041. Epub 2008 Feb 14.

PMID:
18281306
7.

Oral glucose loading for detection of mitochondrial toxicity during HAART in HIV-infected patients.

ter Hofstede HJ, Borm GF, Koopmans PP.

Curr HIV Res. 2007 Jul;5(4):389-93.

PMID:
17627501
8.

Lopinavir/ritonavir reduces lamotrigine plasma concentrations in healthy subjects.

van der Lee MJ, Dawood L, ter Hofstede HJ, de Graaff-Teulen MJ, van Ewijk-Beneken Kolmer EW, Caliskan-Yassen N, Koopmans PP, Burger DM.

Clin Pharmacol Ther. 2006 Aug;80(2):159-68.

PMID:
16890577
9.

Antiretroviral therapy in HIV patients: aspects of metabolic complications and mitochondrial toxicity.

ter Hofstede HJ, Burger DM, Koopmans PP.

Neth J Med. 2003 Dec;61(12):393-403. Review. No abstract available.

10.
11.

[Therapy of HIV infection: how early and how intensive?].

ter Hofstede HJ, Telgt DS, Koopmans PP.

Ned Tijdschr Geneeskd. 2001 Feb 3;145(5):201-4. Dutch. Erratum in: Ned Tijdschr Geneeskd 2001 Apr 7;145(14):712.

PMID:
11219144
12.

The ADAM study continued: maintenance therapy after 50 weeks of induction therapy.

Reijers MH, Weverling GJ, Jurriaans S, Roos MT, Wit FW, Weigel HM, Ten Kate RW, Mulder JW, Richter C, Ter Hofstede HJ, Sprenger H, Hoetelmans RM, Schuitemaker H, Lange JM.

AIDS. 2001 Jan 5;15(1):129-31. No abstract available.

PMID:
11192858
13.

Dose-finding study of a once-daily indinavir/ritonavir regimen.

Hugen PW, Burger DM, ter Hofstede HJ, Koopmans PP, Stek M, Hekster YA, Reiss P, Lange JM.

J Acquir Immune Defic Syndr. 2000 Nov 1;25(3):236-45.

PMID:
11115954
14.

Clinical features and risk factors of lactic acidosis following long-term antiretroviral therapy: 4 fatal cases.

ter Hofstede HJ, de Marie S, Foudraine NA, Danner SA, Brinkman K.

Int J STD AIDS. 2000 Sep;11(9):611-6.

PMID:
10997508
15.

Saliva as a specimen for monitoring compliance but not for predicting plasma concentrations in patients with HIV treated with indinavir.

Hugen PW, Burger DM, de Graaff M, ter Hofstede HJ, Hoetelmans RM, Brinkman K, Meenhorst PL, Mulder JW, Koopmans PP, Hekster YA.

Ther Drug Monit. 2000 Aug;22(4):437-45.

PMID:
10942185
16.

Development of an indinavir oral liquid for children.

Hugen PW, Burger DM, ter Hofstede HJ, Koopmans PP, Hekster YA.

Am J Health Syst Pharm. 2000 Jul 15;57(14):1332-9.

PMID:
10918923
17.

Carbamazepine--indinavir interaction causes antiretroviral therapy failure.

Hugen PW, Burger DM, Brinkman K, ter Hofstede HJ, Schuurman R, Koopmans PP, Hekster YA.

Ann Pharmacother. 2000 Apr;34(4):465-70.

PMID:
10772431
18.

Drug reactions to contrimoxazole in HIV infection: possibly not due to the hydroxylamine metabolites of sulphamethoxazole.

ter Hofstede HJ, van der Ven AJ, Koopmans PP.

Br J Clin Pharmacol. 1999 May;47(5):571-3. No abstract available.

19.

[Glucose tolerance test for tracing of mitochondrial toxicity from nucleoside analogs].

Brinkman K, ter Hofstede HJ, Willems J, Burger DM, Koopmans PP.

Ned Tijdschr Geneeskd. 1998 Oct 3;142(40):2231-2. Dutch. No abstract available.

PMID:
10049096
20.

Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway.

Brinkman K, ter Hofstede HJ, Burger DM, Smeitink JA, Koopmans PP.

AIDS. 1998 Oct 1;12(14):1735-44. Review. No abstract available.

PMID:
9792373
21.

[Hepatic steatosis during treatment with zidovudine and lamivudine in an HIV-positive patient].

ter Hofstede HJ, Koopmans PP, van Haelst UJ.

Ned Tijdschr Geneeskd. 1998 Feb 21;142(8):415-9. Dutch.

PMID:
9562777

Supplemental Content

Loading ...
Support Center